Frank Brosius is a Nephrology physician affiliated with University of Arizona. OpenAlex indexes 246 publications with 14,830 citations (h-index 64). By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3838 N Campbell Ave Bldg 2
Tucson, AZ 857191454
Telephone
520-694-8888Provider last certified this registry record 6 Mar 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20231 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.6%Calcium channel blocker14.3%Amlodipine Besylate100%Part D≥11 patientsAngiotensin receptor blocker (ARB)12.7%Losartan Potassium100%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
44.4%SGLT2 inhibitor25.4%Jardiance78%Farxiga22%Part D<11 patientsGLP-1 receptor agonist19%Ozempic100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Arizona Technology Development and Clinical Education Program for Students in Kidney Health (ADVANCE Kidney Health)
University of Arizona
FY2025$140,400R25DK128859 - Arizona Technology Development and Clinical Education Program for Students in Kidney Health (ADVANCE Kidney Health)
University of Arizona
FY2024$140,400R25DK128859 - Arizona Technology Development and Clinical Education Program for Students in Kidney Health (ADVANCE Kidney Health)
University of Arizona
FY2023$140,400R25DK128859
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
Journal of Clinical Investigation
2023 - Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Annals of Internal Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Alpert, MD
University of Arizona
Karl Kern, MD
University of Arizona
Peter Reaven, MD
University of Arizona
Alison Stopeck, MD
University of Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”